Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Renal tubular cell membrane transport proteins are a heterogeneous group of membrane-spanning proteins located on the apical and basolateral membranes of renal epithelial cells. They are essential for the kidney's role in maintaining systemic homeostasis, as they mediate the selective reabsorption of vital substances like glucose, amino acids, and electrolytes from the primary urine, as well as the active secretion of metabolic wastes and drugs (StatPearls, NBK541086). This category includes several families, most notably the Solute Carrier (SLC) family—such as SGLT2, NCC, NKCC2, OATs, and OCTs—and certain ATP-binding cassette (ABC) transporters (PMC3503187). Due to their central role in regulating blood volume, blood pressure, and metabolic levels, these transporters are primary targets for numerous pharmacological interventions, including diuretics for hypertension and heart failure, and SGLT2 inhibitors for type 2 diabetes and chronic kidney disease. Furthermore, these transporters are critical determinants of the pharmacokinetics of many drugs, serving as major sites for renal clearance and potential drug-drug interactions (IUPHAR/BPS Guide to Pharmacology). This entry is marked as incorrect because it represents a broad class of proteins rather than a single specific therapeutic target.
These proteins are targeted by various drugs to inhibit the reabsorption or facilitate the excretion of specific substances across the renal tubular epithelium. For example, SGLT2 inhibitors block glucose reabsorption in the proximal tubule to lower blood sugar, while loop and thiazide diuretics inhibit ion transporters (NKCC2 and NCC, respectively) to promote sodium and water excretion for blood pressure control. Additionally, some drugs inhibit organic anion or cation transporters (OATs/OCTs) to modulate the renal clearance of other medications.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Renal tubular transport proteins.